Najnowsze wersje próbne

EudraCT Number: 2004-000452-16 Sponsor Protocol Number: 156-03-244 Start Date: 2004-08-02
Sponsor Name: Otsuka Maryland Research Institute
Full Title: International, Multi-Centre, Study of One year, Open Label, Titrated Oral Tolvaptan Tablet Administration in Patients with Chronic Hyponatraemia: Extension to Studies 156-02-235 and 156-03-238 to a...
Medical condition: Ongoing hyponatraemia in euvolemic and hypervolemic states
Disease: Version SOC Term Classification Code Term Level
7 10021036 1.1
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) CZ (Completed) ES (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-000312-93 Sponsor Protocol Number: 0431-020 Start Date: 2004-08-02
Sponsor Name: Merck Sharp & Dohme (Sweden) AB
Full Title: A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metfor...
Medical condition: Type 2 Diabetes Mellitus
Disease: Version SOC Term Classification Code Term Level
7.0 10045242 LLT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SE (Completed) AT (Completed) DK (Completed) BE (Completed) IT (Completed)
Trial results: View results
EudraCT Number: 2004-001273-26 Sponsor Protocol Number: CASM981CES02 Start Date: 2004-08-02
Sponsor Name: NOVARTIS FARMACEUTICA, S.A
Full Title: A 3 weeks study randomized, multicenter, double blind, vehicle controlled , parallel-group to evaluate the efficacy and safety of Pimecrolimus cream 1% in children between 2 – 11 years with mild to...
Medical condition: Mild to moderate Atopic Dermatitis
Disease: Version SOC Term Classification Code Term Level
7.0 10003641 LLT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: ES (Completed)
Trial results: View results
EudraCT Number: 2004-002033-39 Sponsor Protocol Number: PAN 2004-01 Start Date: 2004-08-02
Sponsor Name: AZIENDA OSPEDALIERA SAN GERARDO DI MONZA
Full Title: STUDY OF PREOPERATIVE AND POSTOPERATIVE IL-2 IMMUNOTHERAPY IN PANCREATIC CANCER SURGERY - RANDOMIZED PHASE 2 STUDY
Medical condition: PREVENTION OF IMMUNODEFICENCY IN PANCREATIC CANCER UNDERGOING SURGERY
Disease: Version SOC Term Classification Code Term Level
10062012 PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: (No results available)
EudraCT Number: 2004-001548-60 Sponsor Protocol Number: MA17903 Start Date: 2004-08-02
Sponsor Name: F. Hoffmann-La Roche Ltd
Full Title: Double-blind, partially randomized, parallel group, multicenter study to assess the efficacy and safety of 100 mg and 150 mg monthly oral ibandronate in women with postmenopausal osteoporosis havin...
Medical condition: Long term study in women with postmenopausal osteoporosis.
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Female
Trial protocol: HU (Completed)
Trial results: View results
EudraCT Number: 2004-000718-37 Sponsor Protocol Number: RA/PR/033001/005/04 Start Date: 2004-07-30
Sponsor Name: Chiesi Farmaceutici S.p.A.
Full Title: Double blind, double dummy, multinational, multicenter, parallel-group design clinical trial of superiority of CHF 1535 1 puff in a b.i.d regimen administered via an HFA-propellant-pMDI versus a do...
Medical condition: Mild to moderate adult asthmatic patients
Disease: Version SOC Term Classification Code Term Level
7.0 10003553 Low
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: SK (Completed) CZ (Completed)
Trial results: View results
EudraCT Number: 2004-000148-26 Sponsor Protocol Number: SP516 Start Date: 2004-07-30
Sponsor Name: Schwarz BioSciences Inc.
Full Title: A multi-centre, multinational, phase 3, open-label extension trial to assess the safety of long-term treatment of rotigotine patch in subjects with advanced stage, idiopathic Parkinson's disease wh...
Medical condition: Parkinson's Disease
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: FI (Completed) SE (Completed) HU (Completed) ES (Completed) CZ (Completed) IT (Completed) AT (Completed)
Trial results: View results
EudraCT Number: 2004-001673-25 Sponsor Protocol Number: VALSARTAN-TRAPIANTO/04 Start Date: 2004-07-30
Sponsor Name: OSPEDALE S. RAFFAELE
Full Title: EFFECTS OF ANGIOTENSIN RECEPTOR ANTAGONIST ON CHRONIC NEPHROPATY IN KIDNEY TRANSPLANTED PATIENTS. A PILOT STUDY.
Medical condition: CHRONIC NEPHROPATY REDUCTION
Disease: Version SOC Term Classification Code Term Level
6.1 10038359 SOC
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2005-001347-37 Sponsor Protocol Number: GIMEMAAML17(EORTC06012) Start Date: 2004-07-30
Sponsor Name: G.I.M.E.M.A. GRUPPO ITALIANO MALATTIE EMATOLOGICHE DELL'ADULTO
Full Title: Gemtuzumab ozogamicin (GO) combined with standard intensive chemotherapy versus standard intensive chemotherapy alone for induction/consolidation in patients 61-75 years old with previously untre...
Medical condition: Previously untreated primary or secondary AML (including AML after MDS).All FAB subtypes except M3.No AML supervening after other myeloproliferative diseases.Age 61-75 years.
Disease: Version SOC Term Classification Code Term Level
14.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10000880 Acute myeloid leukaemia PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-000383-27 Sponsor Protocol Number: D1803C00002 Start Date: 2004-07-28
Sponsor Name: AstraZeneca AB
Full Title: A double-blind randomized placebo controlled crossover study of AZD7371 ER 5 mg bid, 20 mg bid and placebo treatment for one week on visceral perception and symptoms in patients with Irritable Bowe...
Medical condition: Irritable Bowel Syndrome (IBS)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Male, Female
Trial protocol: SE (Completed)
Trial results: View results

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj